Advanced Eye Protection Against Covid-19 For Healthcare Professionals – an Exclusive Bollé Safety Technology
Bollé Safety, world leader in the design and manufacture of protective eyewear, presents its Healthcare division dedicated to all healthcare professionals. Its range of protective eyewear with anti-fog and anti-scratch PLATINUM® coating provides highly exposed employees with the highest levels of protection, clarity, and vision.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210416005009/en/
@BolléSafety - A.Childeric
Viruses & infections’ protection
Bollé Safety offers certified products compliant with the most stringent international standards. Its anti-fog PPE product range is tailored to protect professionals who are at high risk of being exposed to bodily fluids when providing care to patients. It is the company’s shared commitment to provide the highest quality protection for all healthcare workers.
The importance of a clear vision
Bollé Safety’s unique and exclusive permanent double sided anti-fog and anti-scratch PLATINUM® coating is available on safety glasses and goggles, including prescription glasses. It is the first company in the world to supply all their prescription lenses with PLATINUM® coating, giving all eyewear a high resistance to scratching and delays the onset of fogging. The PLATINUM® technology ensures improved protection and guarantees greater safety, reliability, and comfort in all circumstances.
Most protective eyewear on the market only protects the inside of the lens against fogging, and the outside against scratching. Bollé Safety offers more comprehensive protection by applying its innovative coating on both sides of the lens. PLATINUM® relies on a chemical coating incorporating both hydrophilic materials that absorb moisture and hydrophobic techniques that divert excess moisture to the sides of the lens.
Comfortable equipment you can wear all day long
Our protective eyewear is featherweight and comfortable to be worn all day long. Bollé Safety has worked on adjustable features and smart technologies to make sure that each frame sits perfectly on any face, regardless of its size. Our glasses ensure a comfortable and secure experience and diminish risks in the work environment.
To find more information please visit https://bit.ly/2R6zlWs
_______________________________________________________________
With a wide range of innovative, comfortable, and protective safety eyewear, Bollé Safety has the right equipment for your unique needs. Led by innovation for over 130 years, we develop all our products to go beyond our users’ expectations. Our range of protective eyewear provides all healthcare professionals with the highest levels of protection, clarity, and vision while our lens innovations ensure improved eyes protection.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210416005009/en/
Contact information
Media Contact
Aline CAMPO/Robin SAUNIER-PLUMAZ
+33-(7)-89-67-67-60 / +33-(7)-64-55-36-09
E-mail: marketing@bolle-safety.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phenom Expands Applied AI Leadership: Enterprise Talent Optimization & Work Redesign, Frontline Workforce Lifecycle & Shift Scheduling, and Unified Orchestration Engine7.11.2025 12:00:00 EET | Press release
Phenom, the leader in applied AI that helps organisations hire faster, develop better and retain longer, announced three new innovations at IAMPHENOM Europe that enhance how companies connect business strategy to talent execution: Enterprise Talent Optimization & Work Redesign, Frontline Workforce Lifecycle & Shift Scheduling, and Unified Orchestration Engine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251107190121/en/ Phenom announced three new innovations at IAMPHENOM Europe that enhance how companies connect business strategy to talent execution: Enterprise Talent Optimization & Work Redesign, Frontline Workforce Lifecycle & Shift Scheduling, and Unified Orchestration Engine. By expanding Phenom’s AI and automation, companies are empowered to rethink how work is designed, talent is mobilised and operations are orchestrated across the full talent lifecycle. By expanding Phenom’s AI and automation, companies are empower
INNIO and KMW Secure Grid Stability and Data Center Supply With a Peaking Power Plant7.11.2025 10:00:00 EET | Press release
INNIO Group has signed a contract with KMW (Kraftwerke Mainz-Wiesbaden AG) for a new 54-MW peaking power plant. A total of twelve modular energy systems from INNIO are intended to be operated at the site. Part of the plant’s capacity is expected to be available for the “Green Rocks” data center, which is being built by KMW and Norwegian data center operator Green Mountain. INNIO’s decentralized energy solutions serve as backup in case of a blackout due to grid failure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251107090386/en/ Visualization of the future Green Rocks data center (c) KMW The power plant is scheduled to be commissioned by the end of 2027. “The partnership between INNIO and KMW is a strategic milestone for energy supply in Mainz. It combines efficiency with future viability and is designed to support the operation of our data center even in the event of a blackout,” said KMW board member Oliver Malerius. “W
Suzano Reports Increased Operational Efficiency With Lower Cash Cost in the Third Quarter of 20257.11.2025 00:58:00 EET | Press release
Suzano, the world’s largest pulp producer, announces its results for the third quarter of 2025 (3Q25), reporting sales of 3.6 million tonnes of pulp and paper combined, a 20% increase on the same quarter last year (3Q24). The positive result is driven by the operations of the Ribas do Rio Pardo pulp mill, inaugurated in 2024, and by the integration of paper production from assets acquired in the United States in October 2024. The cash cost of pulp production (excluding downtime) was R$801 per tonne, a 7% reduction compared to 3Q24, another positive highlight of the quarter. The results reflect the continuation of the downward trend in production costs and the ongoing improvement in structural competitiveness. Net revenue for the quarter totalled R$12.2 billion, broadly flat on the comparable period last year. Adjusted EBITDA totalled R$5.2 billion and operating cash generation was positive at R$3.4 billion. The movement is mainly influenced by lower pulp prices and a weaker exchange ra
Vedanta Resources Launches CopperTech Metals to Bolster U.S. Copper Security and Advance Technology and Infrastructure Transformation6.11.2025 18:45:00 EET | Press release
Vedanta Resources Limited ("Vedanta") today announced the launch of CopperTech Metals Inc. ("CopperTech" or the "Company"), a U.S.-domiciled company with a mission to 'Power the Copper Century' and to bolster America's copper security needs while capitalizing on surging copper demand driven by artificial intelligence, data center expansion, grid modernization, defense technologies and industrial onshoring requirements. CopperTech will1 own and operate the Konkola Copper Mines in Zambia, one of the highest-grade copper producing assets in the world with proven cobalt reserves. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251106537189/en/ CopperTech intends to build on the existing $3 billion investment made by Vedanta Resources Limited in the Konkola Copper Mines – which included construction of a deep mine shaft, a smelter and a concentrator, and engaging in general mine development – and intends to invest an additional $1
NJ Bio Bridges the Translation Research Gap with the Asset Purchase and Integration of L2P ® Services6.11.2025 18:11:00 EET | Press release
NJ Bio, Inc., a premier contract research and clinical manufacturing service provider in Princeton, New Jersey has announced the asset purchase and full integration of the research services of L2P Research Labs® (“Lab to Pharmacy”), further expanding its service portfolio, and bridging the translational research gap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251106703527/en/ NJ Bio, Inc. now offers translational research services after completing asset purchase and full integration of the services of L2P® Research Labs, enhancing the discovery-to-development pipeline Currently, the attrition rate of biological molecules moving past phase 1 clinical trials is very high and the way to overcome this challenge is through translational research. NJ Bio specializes in preclinical and early-phase clinical research and development, with a primary focus on ADCs, bioconjugation, custom synthesis, oligonucleotides, and mRNAs. Howe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom